New insights on chemically induced animal models of systemic sclerosis
Authors:
- Frédéric BatteuxFBFrédéric Batteux
- Niloufar KavianNKNiloufar Kavian
- Amélie ServettazASAmélie Servettaz
- 1 November 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 23 (6) , 511-518
Abstract
To discuss the most recent published studies on chemical-induced animal models of systemic sclerosis (SSc) and to precise the important signalling pathways that lead to the initiation and progression of the disease in these models. Environmental factors undoubtedly contribute to the initiation and the development of SSc. Among those factors, bleomycin has been identified as a possible SSc-inducing substance in mice. The bleomycin model mimics the inflammatory changes observed in the early phase of the disease. This model has been extensively studied and has allowed identification of several key pathways activated in the human disease. More recently, a new chemical-induced model of scleroderma has been developed in mice using daily intradermal injections of a solution generating hypochlorous acid (HOCl)-model. This HOCl-model recapitulates the whole spectrum of the human disease, as fibrosis, inflammation, autoimmunity and vasculopathy can be observed in mice and brought new arguments for a major role of reactive oxygen species in the induction of local and systemic fibrosis. Chemically induced models truly develop a SSc-like disease and argue for a crucial role of ROS in SSc.Keywords
This publication has 68 references indexed in Scilit:
- Animal models of systemic sclerosis: Prospects and limitationsArthritis & Rheumatism, 2010
- CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced SclerodermaThe American Journal of Pathology, 2008
- Scleroderma: from cell and molecular mechanisms to disease modelsTrends in Immunology, 2005
- Animal model of sclerotic skin. VI: Evaluation of bleomycin-induced skin sclerosis in nude miceArchives of Dermatological Research, 2003
- In vivo analysis of the apoptosis‐inducing effect of anti–endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assayArthritis & Rheumatism, 2003
- Animal Model of Sclerotic Skin. V: Increased Expression of α-Smooth Muscle Actin in Fibroblastic Cells in Bleomycin-Induced SclerodermaClinical Immunology, 2002
- Animal Model of Sclerotic Skin. IV: Induction of Dermal Sclerosis by Bleomycin is T Cell IndependentJournal of Investigative Dermatology, 2001
- Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strainsArchives of Dermatological Research, 2000
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999
- Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.Journal of Clinical Investigation, 1996